ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

The Dual Syk/JAK Inhibitor Cerdulatinib Antagonizes B-cell Receptor and Microenvironmental Signaling in Chronic Lymphocytic Leukemia.

Matthew D Blunt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.